Raffles Medical Group Ltd (SGX:BSL)
Singapore flag Singapore · Delayed Price · Currency is SGD
0.8850
0.00 (0.00%)
Aug 5, 2026, 5:15 PM SGT

Raffles Medical Group Financials Overview

Millions SGD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
740.31765.57752.43708.04824.95725.23
Revenue Growth
-3.30%1.75%6.27%-14.17%13.75%27.64%
Gross Profit
328.32347.31339.03315.94400.1194.99
Operating Income
82.4885.9785.1108.19213.26118.2
Net Income
67.4870.5762.2490.15143.2184.17
Earnings Per Share
0.040.040.030.050.080.04
EPS Growth
-4.16%14.07%-30.70%-37.16%70.82%25.42%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Hospital Services
353.99357.82345.65330.59316.28346.1
Healthcare Services
263.12285.9295.05283.43445.04458.75
Insurance Services
178.86185.23177.99144.45115.02-
Investment Holdings
44.4244.3144.8945.2245.8939.69
Elimination of Inter-Segment
-100.34-107.97-112.02-96.77-99.3-120.75
Total
740.04765.3751.56706.92822.92723.79

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
262.3310.79343.67343.6253.13264.99
Total Debt
34.1887.4288.17124.7129.18234.28
Net Cash (Debt)
228.12223.37255.5218.9123.9530.71
Net Cash Growth
2.13%-12.58%16.72%76.61%303.65%-
Net Cash Per Share
0.120.120.140.120.070.02

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
109.28101.3386.25189.31196.23160.11
Capital Expenditures
-8.06-7.87-19.27-20.53-25.01-49.94
Free Cash Flow
101.2293.4666.98168.79171.21110.17
Free Cash Flow Growth
8.30%39.53%-60.31%-1.42%55.40%48.34%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
44.35%45.37%45.06%44.62%48.50%26.89%
Operating Margin
11.14%11.23%11.31%15.28%25.85%16.30%
Pretax Margin
12.00%12.23%11.56%16.87%23.19%15.94%
Profit Margin
9.12%9.22%8.27%12.73%17.36%11.61%
FCF Margin
13.67%12.21%8.90%23.84%20.75%15.19%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.0300.0300.0250.0240.0380.018
Dividend Per Share Growth
20.00%20.00%4.17%-36.84%111.11%-28.00%
Dividend Yield
3.39%3.03%3.11%2.40%3.02%1.49%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
24.2426.6025.3822.2518.1230.41
Forward PE
26.1125.6921.3621.3924.5245.67
P/FCF Ratio
16.0920.0823.5811.8815.1623.23
PS Ratio
2.202.452.102.833.153.53